Although statins are powerful lipid-lowering drugs, many patients with hypercholesterolemia do not reach current treatment goals with statin treatment. Ezetimibe the first approved direct ...
Ezetimibe is a nonstatin low-density lipoprotein cholesterol-lowering small molecule drug. Ezetimibe is the only currently FDA-approved approved member of the of intestinal cholesterol reuptake ...
Other medications could interact with your ... These alternatives to statins also have side effects. Ezetimibe blocks cholesterol absorption in your gut, which can cause diarrhea or stomach ...
FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.
In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...
“The approved drugs, alirocumab and evolocumab, reduce LDL cholesterol by about 60% alone and up to 85% when combined with ...
High peak sales projections for drugs to treat high cholesterol haven’t always ... recently renegotiated European rights to Nilemdo and ezetimibe combo product Nustendi, paying a second $150 ...
Ezetimibe is a novel drug used for the inhibition of intestinal cholesterol absorption. It effectively reduces cholesterol absorption by approximately 54%, leading to a reduction in LDL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback